|
CN102793972A
|
|
Treating inflammatory disorders by electrical vagus nerve stimulation
|
|
US2005222123A1
|
|
Cholinesterase inhibitors for treating inflammation
|
|
BRPI0407410A
|
|
method for treating hypothyroidism
|
|
AU2003298939C1
|
|
Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
|
|
AU2003297297A1
|
|
Elf3 gene compositions and methods
|
|
AU2003299526A8
|
|
Novel human elastases and stress urinary incontinence
|
|
EP1487494A2
|
|
Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
|
|
AU2002365941A1
|
|
Methods of diagnosis, monitoring and treatment of fertility
|
|
WO03031574A2
|
|
Elastase inhibitors
|
|
CN1516739A
|
|
Use of HMG fragments as anti-inflammatory agents
|
|
US6610726B2
|
|
Compositions and agents for modulating cellular proliferation and angiogenesis
|
|
AU1339502A
|
|
Method for promoting hair growth
|
|
US6833244B1
|
|
Oligonucleotides for detecting male infertility
|
|
WO0218574A2
|
|
Human interleukin-four induced protein
|
|
CA2452445A1
|
|
Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
|
|
US6589997B2
|
|
Small-molecule modulators of hepatocyte growth factor/scatter factor activities
|
|
US6610713B2
|
|
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
|
AU2045601A
|
|
Methods and agents for the inhibition of smooth muscle cell proliferation
|
|
WO0137853A2
|
|
Methods and agents for the inhibition of smooth muscle cell proliferation
|
|
US6649588B1
|
|
Inhibition of TGF-β and uses thereof
|
